Clinical Trial Update: A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population [Phase 2]

View source ↗

Summary

Phase 2 maintenance trial in non-progressing metastatic stage IVA/IVB non-squamous non-small cell lung cancer comparing pazopanib to pemetrexed; the study was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Votrient (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Small Cell | Phase 2 | Status: TERMINATED | Results posted: 2013-04-29